15 rezultatima
BACKGROUND OF THE INVENTION
The present invention relates to cervical carcinoma cells (HeLa) modified with a nitrate reductase gene fragment.
U.S. Pat. No. 5,003,050, "Diazoluminomelanin and a method for preparing same", issued Mar. 26, 1991 to Kiel et al, describes a polymeric water-soluble
BACKGROUND OF THE INVENTION
The present invention relates to murine mammary carcinoma cells modified with a nitrate reductase gene fragment.
One of the most pressing health issues today is breast cancer. In the industrial world, about one woman in every nine can expect to develop breast cancer in
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method of "green" biosynthesis of noble metal nanoparticles using dead cancer cells as a reducing agent.
2. Description of the Related Art
Nanotechnology is emerging as a rapidly growing field primarily for
This invention relates to an organic complex of platinum, a process for preparing it and its therapeutic use for the treatment of malignant tumours.
According to one aspect of the invention, there is provided as a novel chemotherapeutic agent having anti-tumour activity cis-isocitrato
FIELD OF THE INVENTION
THIS INVENTION relates to metal complexes of aryl phosphines and processes for their preparation.
BACKGROUND OF THE INVENTION
Although platinum anti-cancer drugs are currently the only metal compounds in clinical use for cancer chemotherapy, many other metal complexes have
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a method of separating Cesium-131 (Cs-131) from Barium (Ba). Uses of the Cs-131 purified by the method include cancer research and treatment, such as for use in brachytherapy implant seeds independent of
BACKGROUND OF THE INVENTION
The present invention relates to novel bis-platinum complexes and to pharmaceutical compositions containing them.
While cisplatin is widely used because of its antitumor activity, the search has continued for more powerful agents.
U.S. Pat. No. 4,225,529, discloses a cis
BACKGROUND OF THE INVENTION
The present invention relates to novel bis-platinum complexes and to pharmaceutical compositions containing them.
While cisplatin is widely used because of its antitumor activity, the search has continued for more powerful agents.
U.S. Pat. No. 4,225,529, discloses a cis
BACKGROUND
Loss of bone mass (osteopenia or osteoporosis) and accelerated loss of calcium from bone are major causes of medical illness. Increased bone resorption is commonly associated with many different diseases. These problems affect millions of persons in the U.S. alone. Examples of disorders
TECHNICAL FIELD
The present invention pertains to a urinalysis reagent and, in particular relates to a reagent for detection of urine monophenolic metabolites and a method for preparing the reagent, in which the monophenolic metabolites, for example, tyrosine, p-hydroxyphenyl alanine, tryptophan and
The present invention relates to the use of 2-alkoxyphenyl-substituted imidazotriazinones for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic
The present invention relates to the use of 2-alkoxyphenyl-substituted imidazotriazinones for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic
BACKGROUND OF THE INVENTION
This invention relates to new platinum complexes in which the platinum cation is coordinated to heterocyclic sulfur compounds as well as monofunctional or bidentate amines. It relates also to a method for using these complexes to treat neoplastic disease in
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation.
EXAMPLE 1
A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%
BACKGROUND OF THE INVENTION
The present invention relates to novel bis[bis(diphenylphosphino)hydrocarbon]- and bis[diphenylphosphinodiphenylarsino)hydrocarbon]-group VIII metal compounds, which have tumor cell growth-inhibiting activity, novel pharmaceutical compositions containing tumor cell